Ara
Toplam kayıt 92, listelenen: 11-20
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds
(Elsevier Science Inc, 2020)
BACKGROUND The vast majority of clinical trials regarding bioresorbable vascular scaffold (BVS) use came from comparison of everolimus-eluting scaffolds with metallic stents, and it remains unclearwhether similar results ...
Real-world data from the Turkish national chronic lymphocytic leukemia registry
(CIG Media Group, 2020)
Objective: We have previously established a nationwide registry to obtain real-world data to document the demographics and treatment outcomes of Turkish CLL patients. Patients or other participants: Patients who were ...
Trends of primary glomerular disease in Turkey from 2009 to 2017: A regional registry report from TSN-Gold working group
(Oxford University Press, 2020)
...
Characteristics of primary glomerular disease patients with hematuria in Turkey: The data from TSN-Gold working group
(Oxford University Press, 2020)
...
Adult minimal change disease in Turkey: The results of Turkish society of nephrology glomerular diseases working group
(Oxford University Press, 2020)
...
Rituximab-vemurafenib combination for the treatment of relapsed/Refractory hairy cell leukemia
(CIG Media Group, 2020)
Objective: The management of R/R-HCL is not standardized yet. Patients with HCL universally harbor BRAF mutations, which makes BRAF inhibitors a potential treatment approach. The effi cacy and safety of the BRAF inhibitor ...